BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

785 related articles for article (PubMed ID: 37934614)

  • 1. Gut microbiome-targeted therapies for Alzheimer's disease.
    Zhang T; Gao G; Kwok LY; Sun Z
    Gut Microbes; 2023 Dec; 15(2):2271613. PubMed ID: 37934614
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Dysfunction of the Microbiota-Gut-Brain Axis in Neurodegenerative Disease: The Promise of Therapeutic Modulation With Prebiotics, Medicinal Herbs, Probiotics, and Synbiotics.
    Peterson CT
    J Evid Based Integr Med; 2020; 25():2515690X20957225. PubMed ID: 33092396
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A Comprehensive Review on the Role of the Gut Microbiome in Human Neurological Disorders.
    Sorboni SG; Moghaddam HS; Jafarzadeh-Esfehani R; Soleimanpour S
    Clin Microbiol Rev; 2022 Jan; 35(1):e0033820. PubMed ID: 34985325
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Dysbiosis and Alzheimer's disease: role of probiotics, prebiotics and synbiotics.
    Thakkar A; Vora A; Kaur G; Akhtar J
    Naunyn Schmiedebergs Arch Pharmacol; 2023 Nov; 396(11):2911-2923. PubMed ID: 37284896
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The Potential Role of Gut Microbiota in Alzheimer's Disease: From Diagnosis to Treatment.
    Varesi A; Pierella E; Romeo M; Piccini GB; Alfano C; Bjørklund G; Oppong A; Ricevuti G; Esposito C; Chirumbolo S; Pascale A
    Nutrients; 2022 Feb; 14(3):. PubMed ID: 35277027
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Anorexia nervosa and gut microbiome: implications for weight change and novel treatments.
    Wei Y; Peng S; Lian C; Kang Q; Chen J
    Expert Rev Gastroenterol Hepatol; 2022 Apr; 16(4):321-332. PubMed ID: 35303781
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effects and Mechanisms of Probiotics, Prebiotics, Synbiotics, and Postbiotics on Metabolic Diseases Targeting Gut Microbiota: A Narrative Review.
    Li HY; Zhou DD; Gan RY; Huang SY; Zhao CN; Shang A; Xu XY; Li HB
    Nutrients; 2021 Sep; 13(9):. PubMed ID: 34579087
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The effect of microbiome therapy on COVID-19-induced gut dysbiosis: A narrative and systematic review.
    Yousef M; Rob M; Varghese S; Rao S; Zamir F; Paul P; Chaari A
    Life Sci; 2024 Apr; 342():122535. PubMed ID: 38408636
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Crosstalk between Gut and Brain in Alzheimer's Disease: The Role of Gut Microbiota Modulation Strategies.
    Shabbir U; Arshad MS; Sameen A; Oh DH
    Nutrients; 2021 Feb; 13(2):. PubMed ID: 33669988
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Human Gut Microbiome: A New Frontier in Cancer Diagnostics & Therapeutics.
    Rani V; Singhal S; Sharma K; Vaid R; Aggarwal K; Bhadana R; Agarwal R; Atale N
    Curr Pharm Des; 2021; 27(45):4578-4592. PubMed ID: 34620056
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Different Strategies Targeting Gut Microbiota for the Management of Several Disorders: A Sustainable Approach.
    Chowdhury M; Raj Chaudhary N; Kaur P; Goyal A; Sahu SK
    Infect Disord Drug Targets; 2024; 24(5):e160124225675. PubMed ID: 38317473
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pancreatic Cancer and Gut Microbiome-Related Aspects: A Comprehensive Review and Dietary Recommendations.
    Sobocki BK; Kaźmierczak-Siedlecka K; Folwarski M; Hawryłkowicz V; Makarewicz W; Stachowska E
    Nutrients; 2021 Dec; 13(12):. PubMed ID: 34959977
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Targeting gut microbiota to alleviate neuroinflammation in Alzheimer's disease.
    Thu Thuy Nguyen V; Endres K
    Adv Drug Deliv Rev; 2022 Sep; 188():114418. PubMed ID: 35787390
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Gut Microbiota and Dysbiosis in Alzheimer's Disease: Implications for Pathogenesis and Treatment.
    Liu S; Gao J; Zhu M; Liu K; Zhang HL
    Mol Neurobiol; 2020 Dec; 57(12):5026-5043. PubMed ID: 32829453
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Modulation of gut microbiome in nonalcoholic fatty liver disease: pro-, pre-, syn-, and antibiotics.
    Cho MS; Kim SY; Suk KT; Kim BY
    J Microbiol; 2018 Dec; 56(12):855-867. PubMed ID: 30377993
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Gut microbiota and its metabolites in depression: from pathogenesis to treatment.
    Liu L; Wang H; Chen X; Zhang Y; Zhang H; Xie P
    EBioMedicine; 2023 Apr; 90():104527. PubMed ID: 36963238
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Gut instincts: Unveiling the connection between gut microbiota and Alzheimer's disease.
    Peddinti V; Avaghade MM; Suthar SU; Rout B; Gomte SS; Agnihotri TG; Jain A
    Clin Nutr ESPEN; 2024 Apr; 60():266-280. PubMed ID: 38479921
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Are We What We Eat? Impact of Diet on the Gut-Brain Axis in Parkinson's Disease.
    Alfonsetti M; Castelli V; d'Angelo M
    Nutrients; 2022 Jan; 14(2):. PubMed ID: 35057561
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Modulating the gut microbiota by probiotics, prebiotics, postbiotics, and fecal microbiota transplantation: An emerging trend in cancer patient care.
    Ciernikova S; Sevcikova A; Drgona L; Mego M
    Biochim Biophys Acta Rev Cancer; 2023 Nov; 1878(6):188990. PubMed ID: 37742728
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Modulating Gut Microbiota: An Emerging Approach in the Prevention and Treatment of Multiple Sclerosis.
    Ullah H; Tovchiga O; Daglia M; Khan H
    Curr Neuropharmacol; 2021; 19(11):1966-1983. PubMed ID: 33596808
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 40.